Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 2164-2168, 2006; 10.1373/clinchem.2006.072876
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sgarlato, G. D.
Right arrow Articles by Sussman, H. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sgarlato, G. D.
Right arrow Articles by Sussman, H. H.
Related Collections
Right arrow Oak Ridge Conference
(Clinical Chemistry. 2006;52:2164-2168.)
© 2006 American Association for Clinical Chemistry, Inc.

Abstracts of Oak Ridge Posters

Representational Fragment Amplification: Exponential Amplification of Fragmented cDNA Enables Multimillion-Fold Expression Testing

Gregory D. Sgarlato and Howard H. Sussmana

(Department of Pathology, Stanford University, Stanford, CA;

aaddress correspondence to this author at: Stanford University, Lane Building, L217, Stanford, California 94305; fax 650-725-6902, email hsussman@stanford.edu)

The first 300 words of the full text of this article appear below.

Microarray analysis, which enables the comprehensive examination of many thousands of genes in a single experiment, is a promising method for furthering understanding of disease states. Because of the large amounts of probe required, however, microarray analysis has not been possible for small excision biopsies, fine needle aspirates, and microdissected tissue samples. Linear amplification of target cDNA with T7 RNA polymerase (1) is currently the most common method for the amplification of RNA for microarray analysis and has been validated (2) and optimized(3)(4). Other linear RNA amplification strategies have been developed (5)(6), but these do not generate sufficient amounts of probe for microarray analysis. DNA fragments have been used for enriching populations (7), cloning differences (8), and subtractive screening(9). Representational fragment amplification (RFA) is a method that we have developed for global amplification of cDNA as universally primed fragments. The product of RFA is double-stranded DNA, which can be directly labeled for microarray analysis, screened for genetic variation with traditional probes, analyzed with PCR-based protocols, or stored for future analysis.

To perform RNA isolation, we processed paired nondiseased and diseased cervical biopsy samples from patients diagnosed with squamous cell carcinoma of the cervix as previously described (10). The specimens were anonymized by ILS Bio or Genomics Collaborative and collected with patient consent in compliance with the company Institutional Review Boards and with the Code of Federal Regulations (CFR) 45CFR46.101B. Briefly, tissue samples frozen with liquid nitrogen were ground to a fine powder, transferred to 6-mol/L guanidine-HCL at room temperature, and homogenized by multiple passes through a syringe equipped with an 18-gauge needle. We isolated RNA with a Qiagen RNeasy Midi Kit.

For RFA cDNA synthesis, we used 5 µg of . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.